Literature DB >> 23975021

Effect of abnormal notochord delamination on hindgut development in the Adriamycin mouse model.

Hideaki Sato1, Piotr Hajduk, Shigeyuki Furuta, Munechika Wakisaka, Paula Murphy, Prem Puri, Hiroaki Kitagawa.   

Abstract

BACKGROUND: Adriamycin mouse model (AMM) is a model of VACTERL anomalies. Sonic hedgehog (Shh) pathway, sourced by the notochord, is implicated of anorectal malformations. We hypothesized hindgut anomalies observed in the AMM are the result of abnormal effect of the notochord.
METHODS: Time-mated CBA/Ca mice received two intraperitoneal injections of Adriamycin (6 mg/kg) or saline as control on embryonic day (E) 7 and 8. Fetuses were harvested from E9 to E11, stained following whole mount in situ hybridization with labeled RNA probes to detect Shh and Fork head box F1(Foxf1) transcripts. Immunolocalization with endoderm marker Hnf3β was used to visualize morphology. Embryos were scanned by OPT to obtain 3D representations of expressions.
RESULTS: In AMM, the notochord was abnormally displaced ventrally with attachment to the hindgut endoderm in 71 % of the specimens. In 32 % of the treated embryos abnormal hindgut ended blindly in a cystic structure, and both of types were remarked in 29 % of treated embryos. Endodermal Shh and mesenchymal Foxf1 genes expression were preserved around the hindgut cystic malformation.
CONCLUSIONS: The delamination of the developing notochord in the AMM is disrupted, which may influence signaling mechanisms from the notochord to the hindgut resulting in abnormal patterning of the hindgut.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23975021     DOI: 10.1007/s00383-013-3386-5

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  31 in total

1.  Relationship of the notochord to foregut development in the fetal rat model of esophageal atresia.

Authors:  B Q Qi; S W Beasley
Journal:  J Pediatr Surg       Date:  1999-11       Impact factor: 2.545

Review 2.  Optical projection tomography as a new tool for studying embryo anatomy.

Authors:  James Sharpe
Journal:  J Anat       Date:  2003-02       Impact factor: 2.610

3.  Abnormal separation of the respiratory primordium in the adriamycin mouse model of tracheoesophageal malformations.

Authors:  Michael J Dawrant; Shay Giles; John Bannigan; Prem Puri
Journal:  J Pediatr Surg       Date:  2007-02       Impact factor: 2.545

Review 4.  Transcription factors in mouse lung development and function.

Authors:  R H Costa; V V Kalinichenko; L Lim
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-05       Impact factor: 5.464

5.  Anorectal malformations caused by defects in sonic hedgehog signaling.

Authors:  R Mo; J H Kim; J Zhang; C Chiang; C C Hui; P C Kim
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

6.  Notable sequential alterations in notochord volume during development in the Adriamycin rat model.

Authors:  Alan Mortell; John Gillick; Shay Giles; John Bannigan; Prem Puri
Journal:  J Pediatr Surg       Date:  2005-02       Impact factor: 2.545

7.  The forkhead transcription factor Foxf1 is required for differentiation of extra-embryonic and lateral plate mesoderm.

Authors:  M Mahlapuu; M Ormestad; S Enerbäck; P Carlsson
Journal:  Development       Date:  2001-01       Impact factor: 6.868

8.  Optical projection tomography as a tool for 3D microscopy and gene expression studies.

Authors:  James Sharpe; Ulf Ahlgren; Paul Perry; Bill Hill; Allyson Ross; Jacob Hecksher-Sørensen; Richard Baldock; Duncan Davidson
Journal:  Science       Date:  2002-04-19       Impact factor: 47.728

9.  Adriamycin mouse model: a variable but reproducible model of tracheo-oesophageal malformations.

Authors:  Michael J Dawrant; Shay Giles; John Bannigan; Prem Puri
Journal:  Pediatr Surg Int       Date:  2007-05       Impact factor: 2.003

10.  Notochord to endoderm signaling is required for pancreas development.

Authors:  S K Kim; M Hebrok; D A Melton
Journal:  Development       Date:  1997-11       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.